Arcus Ventures

Summary

Arcus Ventures appeared to be the VC, which was created in 2007. The company was established in North America in United States. The main department of described VC is located in the New York.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Biotechnology. The fund has specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Epic Sciences, Cleave Therapeutics, Exosome Diagnostics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The important activity for fund was in 2011. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2015. The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Comparing to the other companies, this Arcus Ventures performs on 4 percentage points less the average number of lead investments.

The fund was created by James B. Dougherty, Steven L. Soignet. Besides them, we counted 2 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Arcus Ventures, startups are often financed by Flybridge Capital Partners, Polaris Partners, NGN Capital. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, NGN Capital, Forbion Capital Partners. In the next rounds fund is usually obtained by Beringea, NGN Capital, Forbion Capital Partners.